Related Experiment Video

Updated: Jul 30, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.2K

Therapies for Inherited Retinal Dystrophies: What is Enough?

Bart P Leroy1, Avril Daly2, Elise Héon3

  • 1Department of Ophthalmology, Ghent University Hospital & Department of Head & Skin, Ghent University, ERN-EYE, Ghent, Belgium; Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Drug Discovery Today
|July 11, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

1.9K
Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

883

Related Experiment Videos

Last Updated: Jul 30, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

21.2K
Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

1.9K
Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

883

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Articles linked to this work by shared authors, journal, and citation graph.

Voretigene Neparvovec (Luxturna) for Biallelic RPE65-Associated Retinal Dystrophy: Systematic Review.

American journal of ophthalmology·2026

Missense variants in KATNA1 alter microtubule dynamics and underlie dominant macular dystrophy.

Research square·2026

Navigating the grey areas of life: exploring the lived experiences of children and adolescents with visual impairment.

Disability and rehabilitation·2026

Recruiting children and young people with vision impairment for clinical research - experience from the SeeMyLife study.

BMC medical research methodology·2026

PCR-confirmed severe geographic HSV-1 keratitis associated with systemic JAK inhibitor therapy.

Journal of ophthalmic inflammation and infection·2026

Diagnosis and Metabolic Management of Adult Refsum Disease: Guidance From the Medical and Scientific Committee of Global DARE (Defeat Adult Refsum Everywhere).

Journal of inherited metabolic disease·2026

Mutant isocitrate dehydrogenase in cancer: Structural biology, small-molecule inhibitors, and future drug discovery strategies.

Drug discovery today·2026

The shelved pipeline: AI can find strategically abandoned medicines and bring them to patients.

Drug discovery today·2026

AI-augmented evidence as the next core competence in rare disease drug development: from snapshots to 360-degree movies.

Drug discovery today·2026

From chemical space to synthetic reality: A framework for makeable-by-design generative AI in drug discovery.

Drug discovery today·2026

From diligence to verification: the emergence of the TechBio-Investor.

Drug discovery today·2026

Rare disease benchmarks: Investment professionals' accuracy and beliefs.

Drug discovery today·2026

Alterations in Corpus Callosum Subregion Microstructure Associated With Visual Dysfunction in Individuals With Cerebral Visual Impairment.

Behavioural neurology·2026

Faricimab in the Treatment of Retinal Disease: A Narrative Review.

Cureus·2026

Optic Nerve Head Cotton Wool Spots Mimicking Inflammatory Optic Neuropathy in Central Retinal Vein Occlusion.

Cureus·2026

Associations of Cone Density and Choroidal Thickness with Age: A Cross-Sectional Study.

Ophthalmology science·2026

A half century of research in amblyopia - A psychophysicist's (very) personal perspective.

Vision research·2026

Association Between Subretinal Hyperreflective Material and OCTA-Derived Macular Neovascularization Morphology in Treatment-Naive Neovascular Age-Related Macular Degeneration.

Photodiagnosis and photodynamic therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us